| Abstrakt: |
Drugs and Therapies, Gastroenterology, Health and Medicine, Nerve Tissue Proteins, Neuropeptides, Pancreas, Pancreatic Hormones, Peptide Hormones, Peptide Proteins, Pituitary Hormone Release Inhibiting Hormones, Placebos, Somatostatin, Surgery Keywords for this news article include: Heidelberg University Hospital, Heidelberg, Germany, Europe, Surgery, Placebos, Somatostatin, Neuropeptides, Gastroenterology, Peptide Hormones, Peptide Proteins, Drugs and Therapies, Health and Medicine, Pancreatic Hormones, Nerve Tissue Proteins, Pituitary Hormone Release Inhibiting Hormones. Keywords: Drugs and Therapies; Gastroenterology; Health and Medicine; Nerve Tissue Proteins; Neuropeptides; Pancreas; Pancreatic Hormones; Peptide Hormones; Peptide Proteins; Pituitary Hormone Release Inhibiting Hormones; Placebos; Somatostatin; Surgery EN Drugs and Therapies Gastroenterology Health and Medicine Nerve Tissue Proteins Neuropeptides Pancreas Pancreatic Hormones Peptide Hormones Peptide Proteins Pituitary Hormone Release Inhibiting Hormones Placebos Somatostatin Surgery 558 558 1 03/27/23 20230327 NES 230327 2023 MAR 27 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Research findings on pituitary hormone release inhibiting hormones are discussed in a new report. [Extracted from the article] |
